FOCL FocalTherics
FocalTherics (FOCL) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: August 14, 2026 , by LEVINE JOSHUA .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| WILLSEY LANCE | Director | Buy | 50,000 | $4.75 | $237.5K | 1,291,780 | |
| Rhodes Ryan | Chief Executive Officer | Buy | 21,000 | $4.75 | $99.8K | 626,649 | |
| Horn David R. | Director | Buy | 10,000 | $4.75 | $47.5K | 10,000 | |
| Schulz Fran | Director | Buy | 10,000 | $4.75 | $47.5K | 15,100 | |
| LEVINE JOSHUA | Director | Buy | 10,000 | $4.75 | $47.5K | 45,000 | |
| Annen Steven | SVP, Marketing & Product Mgmt. | Buy | 5,000 | $4.75 | $23.8K | 136,490 | |
| Mobeck Kenneth S. | Chief Financial Officer | Buy | 5,000 | $4.75 | $23.8K | 181,610 | |
| Shah Sanket | General Counsel & Corp Sec | Buy | 5,000 | $4.75 | $23.8K | 72,500 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.